Drug intelligence / Profile preview

ActivBraid

Development stage
Preclinical
Lead developer
Embody
Modality
Fragment-Derived Small Molecules → Multivalent & Scaffold-Based Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
Administration
Surgical Implantation
01

Overview

ActivBraid is a structural medical device and biologic composed of a dehydrated human placental collagen matrix, processed into a braided suture-like format. Developed by MiMedx, it is primarily indicated for the reinforcement and repair of tendons and ligaments in orthopedic and sports medicine applications. The product leverages the inherent biocompatibility and mechanical strength of placental-derived Type I, III, and IV collagen to provide a structural scaffold that supports cellular attachment, proliferation, and tissue remodeling. Unlike synthetic sutures, ActivBraid is designed to integrate into the host tissue over time, facilitating a more natural healing process by utilizing the complex extracellular matrix components found in placental tissue. It is intended to offer a biological alternative or supplement to traditional fixation methods, aiming to improve long-term functional outcomes in reconstructive procedures.

Brand names
ActivBraid
Other names
Braided placental collagen suture
02

Targets

COL4 (Collagen IV)COL1 (Collagen type I)

Beyond the preview

Go deeper on ActivBraid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ActivBraid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call